Donald Jensen to Protease Inhibitors
This is a "connection" page, showing publications Donald Jensen has written about Protease Inhibitors.
Connection Strength
1.482
-
Faldaprevir, pegylated interferon, and ribavirin for treatment-na?ve HCV genotype-1: pooled analysis of two phase 3 trials. Ann Hepatol. 2016 May-Jun; 15(3):333-49.
Score: 0.566
-
Pegylated interferon based therapy with second-wave direct-acting antivirals in genotype 1 chronic hepatitis C. Liver Int. 2015 Jan; 35 Suppl 1:11-7.
Score: 0.516
-
Future directions in therapy for chronic hepatitis C. Antivir Ther. 2008; 13 Suppl 1:31-6.
Score: 0.318
-
Hepatitis C: current and future therapies. Mt Sinai J Med. 2008 Aug; 75(4):405-14.
Score: 0.083